Share-based Payment Arrangement, Expense in USD of Maze Therapeutics, Inc. from Q1 2024 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Maze Therapeutics, Inc. quarterly Share-based Payment Arrangement, Expense history and change rate from Q1 2024 to Q3 2025.
Maze Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $3.86M, a 64.9% increase year-over-year.

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Maze Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2025		$3.86M	+$1.52M	+64.9%	Jul 1, 2025	Sep 30, 2025	10-Q	2025-11-06
Q2 2025		$3.24M	+$1.1M	+51.1%	Apr 1, 2025	Jun 30, 2025	10-Q	2025-08-12
Q1 2025		$3.23M	+$916K	+39.7%	Jan 1, 2025	Mar 31, 2025	10-Q	2025-05-14
Q3 2024		$2.34M			Jul 1, 2024	Sep 30, 2024	10-Q	2025-11-06
Q2 2024		$2.14M			Apr 1, 2024	Jun 30, 2024	10-Q	2025-08-12
Q1 2024		$2.31M			Jan 1, 2024	Mar 31, 2024	10-Q	2025-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.